Summary
PET radiotracer methods can measure various biochemical features of brain tissue in the living human brain. Here, local brain energy consumption and striatal dopaminergic function will be discussed in the light of the neurodegenerative processes underlying Parkinson’s disease. Particularly, disease progression and its consequences for protective and restorative strategies will be outlined. Also, an example will be given to demonstrate how the effect of neurotrophic factors on the striatal dopaminergic system can be monitored by PET tracer methods.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S, Fahn S (1994) The metabolic anatomy of Parkinsonism. J Cereb Blood Flow Metabol 14: 783–801
Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Belakhlef A, Mandel F, Przedborski S, Fahn S (1995a) Early differential diagnosis of Parkinson’s disease with 18F-fluorodeoxy-glucose and positron emission tomography. Neurology 45: 1995–2004
Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Robeson W, Dahl R, Margouleff D (1995b) Assessment of disease severity in Parkinsonism with fluorine-18-fluorodeoxy-glucose and PET. J Nucl Med 36: 378–383
de Rijk MC, Breteler MMB, Graveland GA, Ott A, van der Meché, Hofman A (1995) Prevalence of Parkinson’s disease in the elderly: the Rotterdam study. Neurology 45: 2143–2146
Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252–255
Leenders KL (1990) Cerebral energy metabolism and blood flow in Parkinson’s disease. In: Martin WRW (ed) Functional imaging in movement disorders. CRC Press, Boca Raton Ann Arbor, Boston, pp 115–130
Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, Marsden CD (1986) Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography. J Neurol Neurosurg Psychiat 49: 853–860
Leenders KL, Salmon EP, Turton D, Tyrrell P, Perani D, Brooks DJ, Sagar H, Jones T, Marsden CD, Frackowiak RSJ (1990) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson’s disease. Arch Neurology 47: 1290–1298
Marie RM, Rioux P, Eustache F, Travere JM, Lechevalier B, Baron JC (1995) Clues about the functional neuroanatomy of verbal working memory: a study of resting brain glucose metabolism in Parkinson’s disease. European J Neurol 2: 83–94
Morrish PK, Sawle GV, Brooks DJ (1995) Clinical and [F-18]dopa PET findings in early Parkinson’s disease. J Neurol Neurosurg Psychiat 59: 597–600
Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metabol 5:584–590
Tomac A, Lindqvist E, Lin LFH, Ögren SO, Young D, Hoffer BJ, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335–341
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Wien
About this paper
Cite this paper
Leenders, K.L. (1997). Pathophysiology of movement disorders studied using PET. In: Riederer, P., Calne, D.B., Horowski, R., Mizuno, Y., Poewe, W., Youdim, M.B.H. (eds) Advances in Research on Neurodegeneration. Journal of Neural Transmission. Supplementa, vol 50. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6842-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6842-4_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82898-4
Online ISBN: 978-3-7091-6842-4
eBook Packages: Springer Book Archive